BioSpace News Archive

Wilmington, Delaware, United States: The dermal filler market in the U.S. is driven by rising acceptance of anti-aging treatment by elderly individuals globally.

Wilmington, Delaware, United States: In its recent report, Transparency Market Research gives intricate details about the global behavioral health market.

argenx announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended European Commission approval of efgartigimod as an add-on to standard therapy for the treatment of adult patients with generalized myasthenia gravis who are anti-acetylcholine receptor antibody positive.

Pixium Vision SA, a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, announces the appointment of Anja Krammer and August Moretti as members of the company’s Board of Directors.

Celyad Oncology SA, a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell therapies for cancer, announced that the Board of Directors has named Hilde Windels as Chairwoman of the Board of Directors, effective immediately.

Fact.MR – A Market Research and Competitive Intelligence Provider: Diagnostic imaging is an integral part of healthcare industries across many regions of the world.

Wilmington, Delaware, United States: An autoimmune disorder that affects the skin and internal organs is called systemic scleroderma.

Telemedicine, the future of healthcare services, refers to offering assistance to patients from a distance.

Basilea Pharmaceutica Ltd. announced that its license partner, Pfizer Inc., has received a Drug Approval License from the National Medical Products Administration in China, for the intravenous formulation of Cresemba® for the treatment of adult patients with invasive aspergillosis and invasive mucormycosis.

Wilmington, Delaware, United States: Presently, a number of health problems related to stomach such as ulcer, liver, intestinal pain and cancer, and skin related problems are rising rapidly.